表紙
市場調査レポート

不穏下肢症候群:世界の治験レビュー

Restless Legs Syndrome Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 239410
出版日 ページ情報 英文 149 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
不穏下肢症候群:世界の治験レビュー Restless Legs Syndrome Global Clinical Trials Review, H1, 2014
出版日: 2014年06月20日 ページ情報: 英文 149 Pages
概要

当レポートでは、世界の不穏下肢症候群治療薬の臨床試験について調査し、 地域別の臨床試験数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、 中断(一時中止、廃止、打ち切り)された試験のリストなどを提供しており、概略以下の構成でお届けします。

目次

  • イントロダクション
    • 不穏下肢症候群
    • レポートガイダンス
  • 臨床試験:地域別
  • 臨床試験:国別
    • 臨床試験に寄与している主要国 − アジア太平洋地域
    • 臨床試験に寄与している主要5ヵ国 − 欧州
    • 臨床試験に寄与している主要国 − 北米
    • 臨床試験に寄与している主要国 − 中東およびアフリカ
    • 臨床試験に寄与している主要国 − 中南米
  • 臨床試験 BRIC 諸国
  • 臨床試験 G7 諸国
  • 臨床治験 G7 諸国 , 治験ステータス別
  • 臨床試験 E7 諸国
  • 臨床治験 E7 諸国 , 治験ステータス別
  • 相別臨床試験
    • 進行中の治験:相別
  • 臨床試験:治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
    • 主な治験参加企業
  • 有望な治療薬比較
  • 臨床試験プロファイル
    • 臨床試験概要:主要企業
      • GlaxoSmithKline plc
      • Boehringer Ingelheim GmbH
      • UCB SA
      • Pfizer Inc.
      • UCB, Inc.
      • IMPAX Laboratories, Inc.
      • 大塚製薬
      • Luitpold Pharmaceuticals, Inc.
      • Roxane Laboratories, Inc.
      • Mundipharma Research GmbH & Co. KG
      • Neurocare, Inc.
      • GlaxoSmithKline Inc.
      • 協和発酵キリン
      • Boehringer Ingelheim Pharmaceuticals, Inc.
      • Renapharma AB
      • 大日本住友製薬 (Inactive)
      • Schwarzer GmbH
      • axxonis Pharma AG
      • Teva Pharmaceutical Industries Limited
      • アステラス製薬
    • 臨床試験概要:トップレベルの大学 / 研究機関 / 病院
      • Brigham and Women's Hospital
      • Seton Brain & Spine Institute
      • Georgia Health Sciences University
      • East Tennessee State University
      • Saint Thomas Hospital
      • Northeastern Ohio Universities College of Medicine
      • Lowcountry Infectious Diseases
      • Isfahan University of Medical Sciences
      • Sleep HealthCenters
      • The University of South Florida
      • Yazd Medical University
      • Shiraz University of Medical Sciences
      • University of Virginia
      • University of Zurich
      • Nanjing Medical University
      • University Hospital, Bordeaux
      • Sunnybrook Health Sciences Centre
      • University of Thessaly
      • Centers for Disease Control and Prevention
      • Johns Hopkins University
  • 5つの主要な臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2211CTIDB

GlobalData's clinical trial report, "Restless Legs Syndrome Global Clinical Trials Review, H1, 2014" provides data on the Restless Legs Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Restless Legs Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Restless Legs Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Restless Legs Syndrome
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Restless Legs Syndrome to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Restless Legs Syndrome to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Restless Legs Syndrome
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Restless Legs Syndrome Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • UCB S.A.
      • Clinical Trial Overview of UCB S.A.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • XenoPort, Inc.
      • Clinical Trial Overview of XenoPort, Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Otsuka Holdings Co., Ltd.
      • Clinical Trial Overview of Otsuka Holdings Co., Ltd.
      • Impax Laboratories, Inc.
      • Clinical Trial Overview of Impax Laboratories, Inc.
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
      • Boehringer Ingelheim Auslandsbeteiligungs GmbH
      • Clinical Trial Overview of Boehringer Ingelheim Auslandsbeteiligungs GmbH
    • Clinical Trial Overview of Top Institutes / Government
      • National Institute of Neurological Disorders and Stroke
      • Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
      • Brigham and Women's Hospital
      • Clinical Trial Overview of Brigham and Women's Hospital
      • Johns Hopkins University
      • Clinical Trial Overview of Johns Hopkins University
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
      • University of South Florida
      • Clinical Trial Overview of University of South Florida
      • Instituto de Investigaciones del Sueno
      • Clinical Trial Overview of Instituto de Investigaciones del Sueno
      • Nanjing Medical University
      • Clinical Trial Overview of Nanjing Medical University
      • Children's Hospitals and Clinics of Minnesota
      • Clinical Trial Overview of Children's Hospitals and Clinics of Minnesota
      • University Hospital, Bordeaux
      • Clinical Trial Overview of University Hospital, Bordeaux
      • National Institute on Aging
      • Clinical Trial Overview of National Institute on Aging
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials by Region, 2014*
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Restless Legs Syndrome to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Restless Legs Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Restless Legs Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Restless Legs Syndrome to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Restless Legs Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Restless Legs Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Restless Legs Syndrome Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Restless Legs Syndrome Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Restless Legs Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by XenoPort, Inc., 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Impax Laboratories, Inc., 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim Auslandsbeteiligungs GmbH, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of South Florida, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto de Investigaciones del Sueno, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing Medical University, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospitals and Clinics of Minnesota, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Aging, 2014*

List of Figures

  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Restless Legs Syndrome to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Restless Legs Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Restless Legs Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Restless Legs Syndrome to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Restless Legs Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Restless Legs Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Restless Legs Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Restless Legs Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Restless Legs Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top